These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 29932921)

  • 1. MiR-455-3p suppresses renal fibrosis through repression of ROCK2 expression in diabetic nephropathy.
    Wu J; Liu J; Ding Y; Zhu M; Lu K; Zhou J; Xie X; Xu Y; Shen X; Chen Y; Shao X; Zhu C
    Biochem Biophys Res Commun; 2018 Sep; 503(2):977-983. PubMed ID: 29932921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-92d-3p suppresses the progression of diabetic nephropathy renal fibrosis by inhibiting the C3/HMGB1/TGF-β1 pathway.
    Zhang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 33729484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
    Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
    Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
    Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
    Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA NEAT1 promotes extracellular matrix accumulation and epithelial-to-mesenchymal transition by targeting miR-27b-3p and ZEB1 in diabetic nephropathy.
    Wang X; Xu Y; Zhu YC; Wang YK; Li J; Li XY; Ji T; Bai SJ
    J Cell Physiol; 2019 Aug; 234(8):12926-12933. PubMed ID: 30549040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of microRNA-93 inhibits TGF-β1-induced EMT and renal fibrogenesis by down-regulation of Orai1.
    Ma J; Zhang L; Hao J; Li N; Tang J; Hao L
    J Pharmacol Sci; 2018 Apr; 136(4):218-227. PubMed ID: 29551286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ski-related novel protein suppresses the development of diabetic nephropathy by modulating transforming growth factor-β signaling and microRNA-21 expression.
    Wang Y; Liu L; Peng W; Liu H; Liang L; Zhang X; Mao Y; Zhou X; Shi M; Xiao Y; Zhang F; Zhang Y; Liu L; Yan R; Guo B
    J Cell Physiol; 2019 Aug; 234(10):17925-17936. PubMed ID: 30847937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High glucose down-regulates microRNA-181a-5p to increase pro-fibrotic gene expression by targeting early growth response factor 1 in HK-2 cells.
    Xu P; Guan MP; Bi JG; Wang D; Zheng ZJ; Xue YM
    Cell Signal; 2017 Feb; 31():96-104. PubMed ID: 28077323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy.
    Wang HJ; Liu H; Lin YH; Zhang SJ
    Hum Exp Toxicol; 2021 Apr; 40(4):587-595. PubMed ID: 32959695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.
    Xu H; Sun F; Li X; Sun L
    Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminution of microRNA-98 alleviates renal fibrosis in diabetic nephropathy by elevating Nedd4L and inactivating TGF-β/Smad2/3 pathway.
    Zeng Y; Feng Z; Liao Y; Yang M; Bai Y; He Z
    Cell Cycle; 2020 Dec; 19(24):3406-3418. PubMed ID: 33315506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin inhibits extracellular matrix accumulation, inflammation and proliferation of mesangial cells in diabetic nephropathy by regulating H19/miR-143-3p/TGF-β1 axis.
    Xu J; Xiang P; Liu L; Sun J; Ye S
    J Pharm Pharmacol; 2020 Aug; 72(8):1101-1109. PubMed ID: 32391614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
    Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
    Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC01232 targeting miR-1250-3p/MSH2 axis attenuates mesangial cell proliferation and fibrosis in diabetic nephropathy.
    Tu X; Zhang H; Ren H
    Mol Cell Biochem; 2024 Aug; 479(8):2093-2103. PubMed ID: 37642881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-130b increases fibrosis of HMC cells by regulating the TGF-β1 pathway in diabetic nephropathy.
    Ma Y; Shi J; Wang F; Li S; Wang J; Zhu C; Li L; Lu H; Li C; Yan J; Zhang X; Jiang H
    J Cell Biochem; 2019 Mar; 120(3):4044-4056. PubMed ID: 30260005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin Attenuates Endothelial-to-Mesenchymal Transition of Glomerular Endothelial Cells via Regulating miR-497/ROCK in Diabetic Nephropathy.
    Liu F; Zhang S; Xu R; Gao S; Yin J
    Kidney Blood Press Res; 2018; 43(5):1425-1436. PubMed ID: 30212830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
    Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
    Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of miR-27a-3p in diabetic nephropathy via affecting renal fibrosis, mitochondrial dysfunction, and endoplasmic reticulum stress.
    Wu L; Wang Q; Guo F; Ma X; Wang J; Zhao Y; Yan Y; Qin G
    J Cell Physiol; 2021 Feb; 236(2):1454-1468. PubMed ID: 32691413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
    Fu H; Chu D; Geng X
    Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
    Liu B; Qiang L; Wang GD; Duan Q; Liu J
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.